192 related articles for article (PubMed ID: 11730270)
1. Human immunodeficiency virus/acquired immunodeficiency syndrome-associated nephropathy at end-stage renal disease in the United States: patient characteristics and survival in the pre highly active antiretroviral therapy era.
Abbott KC; Hypolite I; Welch PG; Agodoa LY
J Nephrol; 2001; 14(5):377-83. PubMed ID: 11730270
[TBL] [Abstract][Full Text] [Related]
2. Predictors of renal outcome in HIV-associated nephropathy.
Post FA; Campbell LJ; Hamzah L; Collins L; Jones R; Siwani R; Johnson L; Fisher M; Holt SG; Bhagani S; Frankel AH; Wilkins E; Ainsworth JG; Larbalestier N; Macallan DC; Banerjee D; Baily G; Thuraisingham RC; Donohoe P; Hendry BM; Hilton RM; Edwards SG; Hangartner R; Howie AJ; Connolly JO; Easterbrook PJ
Clin Infect Dis; 2008 Apr; 46(8):1282-9. PubMed ID: 18444868
[TBL] [Abstract][Full Text] [Related]
3. Trends in the outcomes of end-stage renal disease secondary to human immunodeficiency virus-associated nephropathy.
Razzak Chaudhary S; Workeneh BT; Montez-Rath ME; Zolopa AR; Klotman PE; Winkelmayer WC
Nephrol Dial Transplant; 2015 Oct; 30(10):1734-40. PubMed ID: 26175146
[TBL] [Abstract][Full Text] [Related]
4. Familial clustering of end-stage renal disease in blacks with HIV-associated nephropathy.
Freedman BI; Soucie JM; Stone SM; Pegram S
Am J Kidney Dis; 1999 Aug; 34(2):254-8. PubMed ID: 10430971
[TBL] [Abstract][Full Text] [Related]
5. HIVAN and medication use in chronic dialysis patients in the United States: analysis of the USRDS DMMS Wave 2 study.
Abbott KC; Trespalacios FC; Agodoa LY; Ahuja TS
BMC Nephrol; 2003 Jul; 4():5. PubMed ID: 12837135
[TBL] [Abstract][Full Text] [Related]
6. HIV-associated nephropathy and end-stage renal disease in children in the United States.
Ahuja TS; Abbott KC; Pack L; Kuo YF
Pediatr Nephrol; 2004 Jul; 19(7):808-11. PubMed ID: 15141343
[TBL] [Abstract][Full Text] [Related]
7. Multiple myeloma and light chain-associated nephropathy at end-stage renal disease in the United States: patient characteristics and survival.
Abbott KC; Agodoa LY
Clin Nephrol; 2001 Sep; 56(3):207-10. PubMed ID: 11597035
[TBL] [Abstract][Full Text] [Related]
8. Improved survival in HIV-infected African-Americans with ESRD.
Macrae J; Friedman AL; Eggers P; Friedman EA
Clin Nephrol; 2005 Aug; 64(2):124-8. PubMed ID: 16114788
[TBL] [Abstract][Full Text] [Related]
9. Is dialysis modality a factor in survival of patients with ESRD and HIV-associated nephropathy?
Ahuja TS; Collinge N; Grady J; Khan S
Am J Kidney Dis; 2003 May; 41(5):1060-4. PubMed ID: 12722041
[TBL] [Abstract][Full Text] [Related]
10. HIV-associated nephropathy: an urban epidemic.
Monahan M; Tanji N; Klotman PE
Semin Nephrol; 2001 Jul; 21(4):394-402. PubMed ID: 11455528
[TBL] [Abstract][Full Text] [Related]
11. Sickle cell nephropathy at end-stage renal disease in the United States: patient characteristics and survival.
Abbott KC; Hypolite IO; Agodoa LY
Clin Nephrol; 2002 Jul; 58(1):9-15. PubMed ID: 12141416
[TBL] [Abstract][Full Text] [Related]
12. Captopril and renal survival in patients with human immunodeficiency virus nephropathy.
Kimmel PL; Mishkin GJ; Umana WO
Am J Kidney Dis; 1996 Aug; 28(2):202-8. PubMed ID: 8768914
[TBL] [Abstract][Full Text] [Related]
13. Effect of highly active antiretroviral therapy on renal failure in human immunodeficiency virus-associated nephropathy.
Takahashi T; Nakamura T; Kanda T; Iwamoto A
Res Commun Mol Pathol Pharmacol; 2004; 115-116():151-6. PubMed ID: 17564314
[TBL] [Abstract][Full Text] [Related]
14. HIV-associated nephropathy.
Winston J; Klotman PE
Mt Sinai J Med; 1998 Jan; 65(1):27-32. PubMed ID: 9458681
[TBL] [Abstract][Full Text] [Related]
15. Presentation of HIV-associated nephropathy and outcome in HAART-treated patients.
Bigé N; Lanternier F; Viard JP; Kamgang P; Daugas E; Elie C; Jidar K; Walker-Combrouze F; Peraldi MN; Isnard-Bagnis C; Servais A; Lortholary O; Noël LH; Bollée G
Nephrol Dial Transplant; 2012 Mar; 27(3):1114-21. PubMed ID: 21745806
[TBL] [Abstract][Full Text] [Related]
16. Pharmacotherapy and treatment options for HIV-associated nephropathy.
Menez S; Hanouneh M; McMahon BA; Fine DM; Atta MG
Expert Opin Pharmacother; 2018 Jan; 19(1):39-48. PubMed ID: 29224373
[TBL] [Abstract][Full Text] [Related]
17. Kidney disease in Africans with HIV and tuberculosis.
Wearne N; Hung R; Bohmer R; Spies R; Omar A; Ash S; Ibrahim F; Miller RF; Booth JW; Lucas SB; Post FA
AIDS; 2019 Jun; 33(7):1207-1213. PubMed ID: 30932966
[TBL] [Abstract][Full Text] [Related]
18. HIV-associated nephropathy: case study and review of the literature.
Ross MJ; Klotman PE; Winston JA
AIDS Patient Care STDS; 2000 Dec; 14(12):637-45. PubMed ID: 11119430
[TBL] [Abstract][Full Text] [Related]
19. HIV-associated nephropathy: outcome and prognosis factors. Groupe d' Etudes Néphrologiques d'Ile de France.
Laradi A; Mallet A; Beaufils H; Allouache M; Martinez F
J Am Soc Nephrol; 1998 Dec; 9(12):2327-35. PubMed ID: 9848787
[TBL] [Abstract][Full Text] [Related]
20. Antiretroviral therapy in the treatment of HIV-associated nephropathy.
Atta MG; Gallant JE; Rahman MH; Nagajothi N; Racusen LC; Scheel PJ; Fine DM
Nephrol Dial Transplant; 2006 Oct; 21(10):2809-13. PubMed ID: 16864598
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]